ETRACS Alerian MLP Index ETN Series B due July 18 2042
AMUB
0 hedge funds and large institutions have $0 invested in ETRACS Alerian MLP Index ETN Series B due July 18 2042 in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0.05% less ownership
Funds ownership: 0.05% → 0% (-0.05%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $3K → $0 (-$3K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3K |
AMUB Hedge Fund Activity: Q4 2019 in Review
0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) for Q4 2019, worth a combined $0 — down 100% from $3K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AMUB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $3K sold.
- 0 institutional investors held ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) as of Q4 2019, down from 1 in Q3 2019.
- Funds reported $0 of ETRACS Alerian MLP Index ETN Series B due July 18 2042 stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS Alerian MLP Index ETN Series B due July 18 2042 positions in Q4 2019 and 1 closed out, a net change of -1 holder.
- The largest ETRACS Alerian MLP Index ETN Series B due July 18 2042 seller in Q4 2019 was UBS Group, an estimated $3K sold.
Based on aggregated 13F filings for Q4 2019.